Banque Pictet & Cie’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.54M Buy
16,937
+5,564
+49% +$2.48M 0.05% 121
2025
Q1
$5.51M Sell
11,373
-670
-6% -$325K 0.04% 140
2024
Q4
$4.85M Buy
12,043
+788
+7% +$317K 0.03% 150
2024
Q3
$5.23M Sell
11,255
-14,009
-55% -$6.52M 0.04% 139
2024
Q2
$11.8M Buy
25,264
+3,024
+14% +$1.42M 0.11% 78
2024
Q1
$9.3M Sell
22,240
-970
-4% -$405K 0.09% 94
2023
Q4
$9.44M Sell
23,210
-3,354
-13% -$1.36M 0.08% 85
2023
Q3
$9.24M Sell
26,564
-1,558
-6% -$542K 0.11% 89
2023
Q2
$9.9M Buy
28,122
+1,215
+5% +$428K 0.09% 109
2023
Q1
$8.48M Buy
26,907
+2,639
+11% +$831K 0.08% 115
2022
Q4
$7.01M Sell
24,268
-22,285
-48% -$6.44M 0.07% 135
2022
Q3
$13.5M Sell
46,553
-14,145
-23% -$4.1M 0.15% 82
2022
Q2
$17.1K Sell
60,698
-24,898
-29% -$7.02K 0.17% 71
2022
Q1
$22.3M Sell
85,596
-6,905
-7% -$1.8M 0.17% 69
2021
Q4
$20.3M Buy
92,501
+57,611
+165% +$12.7M 0.15% 80
2021
Q3
$6.33M Buy
34,890
+980
+3% +$178K 0.07% 127
2021
Q2
$6.84M Sell
33,910
-6,762
-17% -$1.36M 0.08% 122
2021
Q1
$8.74M Buy
40,672
+1,456
+4% +$313K 0.11% 99
2020
Q4
$9.27M Buy
39,216
+37,055
+1,715% +$8.76M 0.13% 88
2020
Q3
$588K Buy
2,161
+316
+17% +$86K 0.01% 245
2020
Q2
$536K Buy
1,845
+140
+8% +$40.7K 0.01% 256
2020
Q1
$406K Hold
1,705
0.01% 277
2019
Q4
$373K Hold
1,705
0.01% 308
2019
Q3
$289K Hold
1,705
0.01% 310
2019
Q2
$313K Hold
1,705
0.01% 289
2019
Q1
$314K Sell
1,705
-560
-25% -$103K 0.01% 290
2018
Q4
$375K Sell
2,265
-940
-29% -$156K 0.01% 289
2018
Q3
$618K Buy
3,205
+1,500
+88% +$289K 0.01% 274
2018
Q2
$290K Hold
1,705
0.01% 318
2018
Q1
$278K Buy
+1,705
New +$278K 0.01% 332